Simulations Plus stock faces October 5 trading deadline
Simulations Plus (SLP) stock is set for its last trading day on October 5, 2026, ahead of its merger with affiliates of Altaris, LLC, with shareholders receiving USD 18.50 per share. Despite a recent 7% revenue increase and improved gross margins, the stock's current price aligns with the cash offer, not conventional earnings. Analysts maintain a "Reduce" consensus with an average price target below the merger price.
95,805 Shares in Simulations Plus, Inc. $SLP Acquired by Bank of America Corp DE
Bank of America Corp DE has acquired 95,805 shares of Simulations Plus, Inc. (NASDAQ:SLP) during the second quarter, valued at approximately $1.75 million. This acquisition makes Bank of America a significant institutional holder, with 0.47% of the company's stock, contributing to the 78.08% institutional ownership. Despite Simulations Plus beating earnings estimates with an EPS of $0.30 and revenue of $21.89 million, analysts largely maintain a "Hold" rating, with an average price target below its current trading price.
Form DEF 14A Simulations Plus Inc For: 1 October By Investing.com
Investing.com reports on Simulations Plus Inc.'s (SLP) DEF 14A filing for October 1. The article provides the title of the SEC filing and notes that the stock symbol SLP was up 0.33%.
Form DEF 14A Simulations Plus Inc For: 1 October
This article announces the filing of Form DEF 14A by Simulations Plus Inc. on October 1st. It provides no further details about the content of the filing, serving primarily as a brief notification of the regulatory document. The article is published by Investing.com.
Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Rating of "Reduce" from Analysts
Simulations Plus, Inc. (NASDAQ:SLP) has received an average "Reduce" rating from eight brokerages, with an average 12-month price target of $17.25, below its current trading price. This cautious analyst sentiment comes despite the company exceeding quarterly earnings and revenue expectations. Institutional investors hold a significant 78.08% stake, while insiders own 19.10%, with a recent director sale noted under a pre-arranged trading plan.
Simulations Plus (NASDAQ:SLP) Stock Crosses Above 200-Day Moving Average - Here's What Happened
Simulations Plus (NASDAQ:SLP) shares recently crossed above their 200-day moving average, reaching $18.42, well above the $16.21 average. The company also surpassed quarterly earnings expectations, reporting an EPS of $0.30 against an estimate of $0.23 and revenue of $21.89 million against a $20.90 million consensus. Despite this, analyst sentiment remains cautious with a consensus "Reduce" rating and an average price target of $17.25.
Simulations Plus Says FDA's Cosmetics Branch Adopts ADMET Predictor
Simulations Plus (SLP) announced that the US Food and Drug Administration's cosmetics branch has adopted its ADMET Predictor software. The article, however, appears to be a premium content piece, requiring a subscription for full access.
Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch
Simulations Plus, Inc. announced that the U.S. FDA's Cosmetics Regulatory Science Branch has licensed its ADMET Predictor® platform to support modern cosmetic safety assessment through integrated exposure and toxicity modeling. This expansion underscores the growing importance of predictive modeling and mechanistic science in regulatory research and reflects the versatility of Simulations Plus' technology beyond pharmaceuticals. The platform provides advanced AI/ML technology, novel descriptors, and predictive models to rapidly assess endpoint properties and systemic exposure.
Simulations Plus, Inc. Expands FDA Adoption Of ADMET Predictor With New Licenses For The Cosmetics Regulatory Science Branch
Simulations Plus, Inc. announced that the U.S. FDA's Cosmetics Regulatory Science Branch has licensed its ADMET Predictor platform. This expansion supports the FDA's computational research for modern cosmetic safety assessment by leveraging advanced AI and machine learning technology for predictive modeling. The platform helps evaluate potential exposure and intrinsic hazards, aligning with the FDA's research into New Approach Methodologies and reinforcing Simulations Plus's role in predictive science across regulated industries.
Squarepoint Ops LLC Sells 58,282 Shares of Simulations Plus, Inc. $SLP
Squarepoint Ops LLC reduced its stake in Simulations Plus, Inc. by 40.8% in Q2, selling 58,282 shares and retaining 84,655 shares valued at $1.55 million. The company's stock has a consensus "Reduce" rating and an average price target of $17.25 from analysts. Despite analyst caution and a stock drop, Simulations Plus exceeded quarterly earnings expectations, reporting $0.30 EPS against an estimated $0.23, and revenue of $21.89 million compared to $20.90 million estimated.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) after the company cut its fiscal 2025 revenue guidance and experienced significant stock declines. Further concerns arose following a large net loss, an impairment charge, and the dismissal of its accounting firm, which cited unresolved issues regarding financial reporting. The law firm is seeking to connect with investors who suffered losses to explore potential claims under federal securities laws.
First Light Asset Management LLC Raises Position in Simulations Plus, Inc. $SLP
First Light Asset Management LLC significantly increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 6.1% in the second quarter, now holding 2.79 million shares valued at approximately $51.1 million, representing 13.81% of the company. Despite positive quarterly earnings that beat analyst expectations, the stock's performance has been cautious, with analysts maintaining a "Reduce" rating and a consensus price target below the current share price. Other institutional investors also adjusted their positions, and a director sold shares in July.
Bank of New York Mellon Corp Takes $1.25 Million Position in Simulations Plus, Inc. $SLP
Bank of New York Mellon Corp has acquired a new stake of 68,095 shares, valued at approximately $1.25 million, in Simulations Plus, Inc. This purchase makes them owners of about 0.34% of the company, with institutional investors collectively holding 78.08% of the stock. Despite the institutional interest, analyst sentiment has weakened, leading to several downgrades to "hold" or "market perform" ratings, with an average target price of $17.25. Simulations Plus recently exceeded quarterly earnings expectations, reporting $0.30 EPS against a $0.23 consensus and revenues of $21.89 million against $20.90 million expected.
Groupe la Francaise Acquires Shares of 127,200 Simulations Plus, Inc. $SLP
Groupe la Francaise acquired 127,200 shares of Simulations Plus, Inc. (NASDAQ:SLP) in the second quarter, valued at approximately $2.33 million, representing about 0.63% of the company. Despite Simulations Plus exceeding quarterly earnings and revenue expectations, analyst sentiment has weakened, leading to several downgrades to "Hold" or "Market Perform" and a consensus "Reduce" rating with an average price target of $17.25. Insider activity also noted a director selling over 4,000 shares in July.
Simulations Plus (NASDAQ:SLP) Beats Estimates Despite Caution
Simulations Plus (NASDAQ:SLP) exceeded earnings and revenue estimates in its latest quarter, driven by demand for its specialized scientific modeling and simulation software in the pharmaceutical industry. Despite the strong operational performance, analyst sentiment remains cautious due to the company's elevated valuation and concerns about sustained growth. The article highlights the balancing act between the company's valuable offerings in healthcare technology and market expectations embedded in its stock price.
Simulations Plus, Inc. (NASDAQ:SLP) Given Consensus Recommendation of "Reduce" by Analysts
Analysts have assigned Simulations Plus, Inc. (NASDAQ:SLP) a consensus "Reduce" recommendation, with an average 12-month price target of $17.25, below its recent trading price of $18.39. Despite the cautious outlook, the company surpassed quarterly expectations with EPS of $0.30 and revenue of $21.89 million. Insider activity shows Director Walter S. Woltosz selling a small portion of his shares, while institutional investors and hedge funds collectively hold a significant stake in the company.
Meros Investment Management LP Makes New $2.38 Billion Investment in Simulations Plus, Inc. $SLP
Meros Investment Management LP has acquired a new stake worth approximately $2.38 billion in Simulations Plus, Inc. (NASDAQ:SLP) during the second quarter, representing 0.64% of the company's stock. Other institutional investors like Royal Bank of Canada and Rhumbline Advisers also increased their positions in SLP. Simulations Plus recently reported strong Q2 earnings, beating analyst estimates, but its stock traded down by 0.1% on Wednesday.
127,874 Shares in Simulations Plus, Inc. $SLP Acquired by Polar Asset Management Partners Inc.
Polar Asset Management Partners Inc. acquired a new position of 127,874 shares in Simulations Plus, Inc. (NASDAQ:SLP) valued at approximately $2.34 million during the 2nd quarter. Institutional investors and hedge funds now own 78.08% of the company's stock. Despite beating quarterly earnings expectations, analyst sentiment is cautious, with a consensus "Reduce" rating and a target price of $17.25.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) for investors who suffered losses following a significant revenue guidance cut, preliminary third-quarter revenue results, and subsequent decline in share value. Further concerns arose after a large net loss, a non-cash impairment charge, and the dismissal of their independent accounting firm, Grant Thornton LLP, which cited unresolved issues regarding segment reporting and internal controls. The firm is encouraging affected investors to contact them for more information regarding the investigation.
Rice Hall James & Associates LLC Purchases Shares of 103,010 Simulations Plus, Inc. $SLP
Rice Hall James & Associates LLC recently acquired 103,010 shares of Simulations Plus, Inc. (NASDAQ:SLP) worth approximately $1.89 million, representing 0.51% of the company. Institutional investors now own 78.08% of the stock. Despite the institutional interest, analysts maintain a "Reduce" rating for Simulations Plus, with an average price target of $17.25, even though the company recently surpassed quarterly earnings and revenue expectations.
Simulations Plus (NASDAQ:SLP): What Is Driving the Debate?
Simulations Plus (NASDAQ:SLP) is experiencing increased market caution despite stronger-than-expected quarterly results, highlighting a disconnect between operational performance and investor sentiment. The company, which specializes in pharmaceutical modeling and simulation software, benefits from growing demand for digital tools in drug development. Valuation concerns and future growth expectations are key factors contributing to the market's cautious stance, even as institutional activity shows continued interest in the stock.
Short Interest in Simulations Plus, Inc. (NASDAQ:SLP) Grows By 59.7%
Short interest in Simulations Plus, Inc. (NASDAQ:SLP) increased by 59.7% in July, reaching 2.84 million shares, which represents 17.4% of outstanding shares and a 5.2 days-to-cover ratio. This surge in short interest comes amidst weakening analyst sentiment, with several firms downgrading the stock to "Hold" or "Market Perform," resulting in a consensus "Reduce" rating and an average price target of $17.25. Despite this bearish trend, the company exceeded quarterly expectations with $0.30 EPS and $21.89 million in revenue.
Quantinno Capital Management LP Boosts Stock Holdings in Simulations Plus, Inc. $SLP
Quantinno Capital Management LP significantly increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 439.1% in the first quarter, now holding 112,259 shares valued at $1.33 million. Despite this, analyst sentiment remains cautious with an average "Reduce" rating and a $17.25 price target, even though the company exceeded its recent quarterly earnings and revenue expectations. Institutional investors and hedge funds collectively own 78.08% of the company's stock.
Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris
Simulations Plus, Inc. announced the expiration of the Hart-Scott-Rodino (HSR) Antitrust Improvements Act waiting period, a key regulatory condition for its acquisition by Altaris, LLC. While this satisfies one major requirement, the acquisition is still contingent on shareholder approval, certain French regulatory approvals, and other customary closing conditions. The transaction is projected to close in the second half of calendar year 2026.
Simulations Plus HSR waiting period expires, Merger with Altaris remains subject to shareholder and French approvals
Simulations Plus announced that the Hart-Scott-Rodino waiting period for its merger with Altaris has expired, fulfilling a key regulatory condition. However, the merger still requires shareholder approval and certain French regulatory approvals. The transaction is anticipated to close in the second half of 2026, provided all remaining conditions are met or waived.
Simulations Plus (SLP) gains HSR clearance for pending Altaris acquisition
Simulations Plus (SLP) announced that it has received Hart-Scott-Rodino (HSR) antitrust clearance for its pending acquisition by Altaris affiliates. This satisfies one key regulatory condition for the merger, which is still subject to shareholder approval and certain regulatory approvals in France. The transaction is currently expected to close in the second half of calendar 2026.
Renaissance Technologies LLC Purchases 161,500 Shares of Simulations Plus, Inc. $SLP
Renaissance Technologies LLC significantly increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by purchasing 161,500 additional shares, bringing their total to 181,500 shares valued at $2.15 million. This move comes despite a cautious analyst sentiment, with several firms downgrading the stock to "Hold" or "Market Perform." Simulations Plus reported better-than-expected quarterly earnings and revenue, but insider Walter S. Woltosz also sold over 4,000 shares.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) after the company cut its fiscal 2025 revenue guidance and disclosed significant accounting issues. The investigation follows a substantial decline in Simulations Plus's share price after these announcements, including a $77.2 million non-cash impairment charge and the dismissal of its independent auditor. Investors who suffered losses are encouraged to contact Johnson Fistel to learn more.
First Eagle Investment Management (SLP) reports 5.30% beneficial stake in Simulations Plus
First Eagle Investment Management, LLC has reported a beneficial ownership of 5.30% in Simulations Plus Inc., totaling 4,674,801.24 shares. The firm acts as an investment adviser for various clients, holding sole voting and dispositive power over 1,070,582 shares. This disclosure, filed under SCHEDULE 13G, indicates a passive investment primarily on behalf of its advisory clients.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) after the company cut its fiscal 2025 revenue guidance and disclosed a significant non-cash impairment charge and the dismissal of its independent registered public accounting firm. The accounting firm, Grant Thornton LLP, subsequently informed the SEC of unresolved issues regarding segment reporting, reporting-unit determinations, and internal control over financial reporting. Investors who suffered losses are encouraged to contact Johnson Fistel for more information.
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of "Reduce" from Analysts
Simulations Plus, Inc. (NASDAQ:SLP) has received a consensus "Reduce" rating from analysts, with an average 12-month price target of $17.25, below its opening price of $18.32. This comes despite the company exceeding quarterly earnings expectations with an EPS of $0.30 and revenue of $21.89 million. Institutional investors own a significant portion of the shares, while a director recently sold 4,177 shares under a pre-arranged trading plan.
Simulations Plus Chief Revenue Officer John Anthony DiBella II sells 1,000 shares for $18,280
Simulations Plus Chief Revenue Officer John Anthony DiBella II sold 1,000 common shares on August 3rd for $18.28 each, totaling $18,280. This transaction reduced his direct holdings to 85,140 shares. The information was generated using AI from a filing with the U.S. Securities and Exchange Commission.
Simulations Plus, Inc. (SLP) CRO sells 1,000 shares under Rule 10b5-1 plan
Simulations Plus, Inc.'s Chief Revenue Officer, John Anthony DiBella II, sold 1,000 shares of common stock on August 3, 2026, at $18.28 per share through a Rule 10b5-1 trading plan. Following this transaction, DiBella directly holds 85,140 shares. The sale was executed automatically and reported via a Form 4 filing.
Simulations Plus (SLP) insider schedules 3,000-share Rule 144 sale and details 10b5-1 trades
Simulations Plus (SLP) insider John Anthony DiBella II has filed a Rule 144 notice to sell 3,000 common shares, valued at $54,690, which originated from previously exercised options. The filing also details three separate 10b5-1 plan sales, each for 1,000 shares, that occurred in May, June, and July 2026, totaling over $49,000. These transactions provide transparency into insider stock divestment under specific regulatory frameworks.
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Simulations Plus, Inc. (NasdaqGS: SLP) to affiliates of Altaris, LLC for $18.50 per share in cash. KSF is seeking to determine if this consideration and the process leading to it are adequate, suspecting the company might be undervalued. Shareholders are invited to contact KSF to discuss their legal rights regarding the proposed transaction.
SLP|Simulations Plus Inc|Price:18.340|Chg%:+0.010
TradingKey provides a comprehensive stock analysis for Simulations Plus Inc (SLP), highlighting its healthy fundamentals, high growth potential, and current "Hold" rating from analysts with an average target price of $19.83. Despite a recent turnaround to a loss, the company's valuation is considered fairly valued within the Healthcare Equipment & Supplies industry, and institutional ownership remains very high. The stock is currently trading sideways, suggesting suitability for range-bound swing trading.
Simulations Plus, Inc. Revenue Breakdown – NASDAQ:SLP
Simulations Plus, Inc. (NASDAQ: SLP) generated a total revenue of $79.18 million USD last year. The Software segment was the top performer, contributing $45.83 million USD, an increase from $41.02 million USD in the prior year. The Americas region was the largest contributor to revenue, accounting for $57.70 million USD last year.
Simulations Plus, Inc. $SLP Stock Position Boosted by First Light Asset Management LLC
First Light Asset Management LLC significantly increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by 33.7% in the first quarter, now owning 13.03% of the company. Despite this, analyst sentiment has weakened, with a consensus "Reduce" rating and an average price target of $17.25. Simulations Plus reported strong quarterly results, exceeding EPS and revenue estimates.
SLP|Simulations Plus Inc|Price:18.340|Chg%:+0.010
Simulations Plus Inc. (SLP) is a biopharma sector provider offering software and consulting services for drug discovery and development, operating through software and services segments. The company's technology is used by pharmaceutical, biotechnology, and regulatory agencies globally. As of Q1 2026, 432 institutions hold shares, and consulting services generated the highest revenue, accounting for 51.78% of total revenue.
SLP|Simulations Plus Inc|Price:18.340|Chg%:+0.010
Simulations Plus Inc (SLP) closed at $18.340 with a slight increase of 0.05%. The company's fundamentals are considered healthy with high growth potential, though its valuation is fairly valued in its industry. Analysts currently rate the stock as "Hold" with a target price of $19.833, indicating an 8.20% upside.
TradingKey: Simulations Plus Inc (SLP) Income Statement Analysis
This article provides an in-depth look at the quarterly and annual income statements for Simulations Plus Inc (SLP) from TradingKey, detailing revenue, cost of revenue, operating expenses, and net income figures over several fiscal years. It offers a comprehensive financial summary, including year-over-year changes for various metrics, and answers frequently asked questions about analyzing the company's income statement. Key financial data like total revenue, net income, and operating profit for recent fiscal years and quarters are highlighted, along with basic and diluted earnings per share.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) after the company significantly cut its fiscal 2025 revenue guidance, leading to a substantial drop in share price. The investigation stems from preliminary quarterly results, revised guidance, a large non-cash impairment charge, and the subsequent dismissal of its independent accounting firm, which cited unresolved concerns regarding segment reporting and internal controls. Investors who suffered losses are encouraged to contact Johnson Fistel for more information.
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
Johnson Fistel, PLLP is investigating Simulations Plus (NASDAQ: SLP) after the company significantly cut its fiscal 2025 revenue guidance and reported a substantial net loss, including a large impairment charge. Further concerns arose when Simulations Plus dismissed its independent accounting firm, Grant Thornton LLP, which subsequently informed the SEC of unresolved issues regarding segment reporting and internal controls. Investors who experienced losses are encouraged to contact Johnson Fistel for more information.
Simulations Plus Sets Shareholder Vote on Cash Merger with Altaris Affiliate
Simulations Plus has scheduled a virtual special shareholder meeting for August 27, 2026, to vote on a proposed cash merger with SP Evolution BidCo II, LLC, an affiliate of Altaris. The deal, which offers shareholders $18.50 per share, representing a 26% premium, is unanimously backed by the board. Shareholders will also vote on a non-binding proposal for merger-related executive compensation and potential adjournments.
Precision Trading with Simulations Plus Inc. (SLP) Risk Zones
Simulations Plus Inc. (SLP) is showing a neutral sentiment across all horizons, leading to a wait-and-see approach. AI models suggest several trading strategies, including a short setup with a high risk-reward ratio, targeting a 16.5% downside. The article details entry, target, and stop-loss zones for position trading, momentum breakout, and risk hedging strategies.
Precision Trading with Simulations Plus Inc. (SLP) Risk Zones
This article provides a detailed analysis of Simulations Plus Inc. (SLP), highlighting a neutral sentiment across all time horizons. It outlines three institutional trading strategies tailored to different risk profiles, including long, breakout, and short setups with specific entry, target, and stop-loss zones. The analysis also points to an exceptional 53.3:1 risk-reward short setup.
Simulations Plus (NASDAQ:SLP) Share Price Crosses Above 200-Day Moving Average - Time to Sell?
Simulations Plus (NASDAQ: SLP) saw its share price move above its 200-day moving average, reaching $18.25 despite cautious analyst sentiment and recent downgrades. The company reported strong quarterly earnings, beating expectations with an EPS of $0.30 and revenue of $21.89 million. While a director recently sold shares, institutional ownership remains high at 78.08%.
Simulations Plus (SLP) to go private in $375M all‑cash sale to Altaris
Simulations Plus (SLP) is set to go private through a $375 million all-cash sale to Altaris, with shareholders receiving $18.50 per share. This represents a 26% premium over the 60-day volume-weighted average price prior to June 15, 2026. The acquisition is expected to close in the second half of 2026, pending shareholder and regulatory approvals, including the expiration of the HSR Act waiting period.
Simulations Plus | 144: Notice of proposed sale of securities pursuant to Rule 144
This article is a notice regarding the proposed sale of securities by Simulations Plus, as governed by Rule 144. It indicates that the company will be selling its securities in accordance with the specified regulatory framework. The filing provides essential information related to this transaction.
Simulations Plus | 144: Notice of proposed sale of securities pursuant to Rule 144
This document is a formal notification regarding the proposed sale of securities by Simulations Plus, carried out under Rule 144 of the Securities Act of 1933. Rule 144 allows for the public resale of restricted and control securities if certain conditions are met. The filing indicates the company's compliance with regulatory requirements for such transactions.
